Graduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, Tokyo, Japan.
Japan Agency for Marine-Earth Science and Technology (JAMSTEC), Kanagawa, Japan.
J Antibiot (Tokyo). 2018 Aug;71(8):741-744. doi: 10.1038/s41429-018-0053-z. Epub 2018 Apr 23.
Saprolegnia parasitica, belonging to oomycetes, is one of virulent pathogen of fishes such as salmon and trout, and causes tremendous damage and losses in commercial aquacultures by saprolegniasis. Previously, malachite green, an effective medicine, had been used to control saprolegniasis. However, this drug has been banned around the world due to its mutagenicity. Therefore, novel anti-saprolegniasis compounds are urgently needed. As a new frontier to discover bioactive compounds, we focused on the deep-sea fungi for the isolation of anti-saprolegniasis compounds. In this paper, on the course of anti-saprolegniasis agents from 546 cultured broths of 91 deep-sea fungal strains, we report a new compound, named quellenin (1) together with three known compounds, diorcinol (2), violaceol-I (3) and violaceol-II (4), from deep-sea fungus Aspergillus sp. YK-76. This strain was isolated from an Osedax sp. annelid, commonly called bone-eating worm, collected at the São Paulo Ridge in off Brazil. Compounds 2, 3 and 4 showed anti-S. parasitica activity. Our results suggest that diorcinol and violaceol analogs and could be good lead candidates for the development of novel agents to prevent saprolegniasis.
寄生性绵霉,属于卵菌,是鲑鱼和鳟鱼等鱼类的一种毒性病原体,寄生性绵霉病会给商业水产养殖业造成巨大的破坏和损失。以前,孔雀绿作为一种有效的药物,曾被用于控制寄生性绵霉病。然而,由于其致突变性,这种药物已在全球范围内被禁用。因此,迫切需要新型的抗寄生性绵霉病化合物。作为发现生物活性化合物的新前沿,我们专注于深海真菌,以分离抗寄生性绵霉病化合物。在本文中,在对 91 株深海真菌的 546 个培养物进行抗寄生性绵霉病药物筛选的过程中,我们从深海真菌 Aspergillus sp. YK-76 中分离得到一个新化合物,命名为 quellenin(1),以及三个已知化合物,二间苯二酚(2)、violaceol-I(3)和 violaceol-II(4)。该菌株是从巴西近海 São Paulo 海脊采集的一种 Osedax sp.环节动物(俗称食骨蠕虫)中分离得到的。化合物 2、3 和 4 表现出抗 S. parasitica 的活性。我们的研究结果表明,二间苯二酚和 violaceol 类似物可能是开发新型抗寄生性绵霉病药物的良好先导候选物。